CSRXP: AMERICAN PATIENTS COUNTING ON CONGRESS TO BUILD ON POSITIVE PROGRESS TOWARD LOWERING DRUG PRICES, NOT GO BACKWARDS

Lawmakers Must Put Patients First And Reject Bogus Big Pharma Rhetoric

Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Friday in response to comments from some lawmakers suggesting a repeal of drug pricing solutions passed as part of the Inflation Reduction Act of 2022.

“Washington finally took a major step forward to begin holding Big Pharma accountable and lowering out-of-control prescription drug prices for millions of Americans struggling to afford their medications,” said CSRxP executive director Lauren Aronson. “Americans who continue to face heart-wrenching decisions about whether to buy groceries or the prescription drugs they need are counting on lawmakers to reject Big Pharma’s repeatedly debunked innovation rhetoric and build on the momentum for action to deliver relief for patients by holding the pharmaceutical industry accountable for its egregious pricing and anti-competitive practices.”

“Critical drug pricing solutions recently passed by Congress, and signed into law by the president, including keeping price hikes below the rate of inflation and ensuring Big Pharma contributes to the most expensive phase of coverage in Medicare Part D, have won substantial bipartisan support in the past — as have additional market-based solutions that should be taken up and passed by Congress, including reforms to crack down on Big Pharma’s patent abuse,” Aronson continued. “Lawmakers, in both parties, should work together to build on the positive momentum to hold Big Pharma accountable by passing additional, market-based solutions to deliver relief for American patients, not consider going backwards by succumbing to Big Pharma’s bogus blame game and debunked rhetoric designed to keep prices high and continue gaming the system to boost profits.”

Read more about how Congress can build on the positive momentum for action to lower drug prices HERE.

Learn more about why Big Pharma’s bogus innovation rhetoric doesn’t add-up HERE.

Learn more about solutions to hold Big Pharma accountable and lower prescription drug prices HERE.